Universitätsklinikum Göttingen

Towards structured data quality assessment in the German medical informatics initiative: Initial approach in the MII demonstrator study (2019) Kamdje-Wabo G, Gradinger T, Löbe M, Lodahl R, Seuchter SA, Sax U, Ganslandt T Conference contribution Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine (2019) Schlenk RF, Weber D, Herr W, Wulf G, Salih HR, Derigs HG, Kuendgen A, et al. Journal article Trainermanual Adipositasschulung für Kinder und Jugendliche. 2: Ernährung (2019) Gellhaus I, Koch B, Tiedjen U, Büssenschütt A, Daas B, Faustin V, Hellmond F, et al. Authored book, Manual Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Epigenetic regulation in myelinating glia: the role of histone 2b monoubiquitination in Schwann cells (2019) Wüst H, Wegener A, Johnson S, Fröb F, Wegner M, Sock E Conference contribution Mutations in the BAF-complex subunit DPF2 are associated with Coffin-Siris syndrome (2019) Vasileiou G, Vergarajauregui S, Endele S, Popp B, Büttner C, Ekici AB, Gerard M, et al. Conference contribution Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 (2019) Hofheinz R, Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al. Conference contribution